Literature DB >> 6190321

A fatal hyperpyrexial response to bleomycin following prior therapy: a case report and literature review.

F Rosenfelt, J Palmer, I Weinstein, B Rosenbloom.   

Abstract

Bleomycin is an effective drug used in the therapy of many malignant diseases. Such toxicities as fever, chills, and pulmonary fibrosis are well known to occur following administration of this drug. A rare fatal hyperpyrexial response has also been noted with this agent. We describe a case of fatal hyperthermia after an injection of bleomycin. Unlike earlier reported cases, our patient developed her reaction following prior uneventful therapy with bleomycin rather than as a response to initial treatment. Factors that may be related to the hyperpyrexial response to bleomycin are discussed and the relevant literature reviewed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6190321      PMCID: PMC2596537     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  10 in total

1.  Corticosteroid and antihistamine modification of bleomycin-induced fever.

Authors:  M M Oken; J Loch
Journal:  Proc Soc Exp Biol Med       Date:  1979-09

2.  A clinical review of bleomycin--a new antineoplastic agent.

Authors:  R H Blum; S K Carter; K Agre
Journal:  Cancer       Date:  1973-04       Impact factor: 6.860

3.  Pyrogenic properties of bleomycin (NSC-125066).

Authors:  C A Dinarello; S B Ward; S M Wolff
Journal:  Cancer Chemother Rep       Date:  1973 Nov-Dec

4.  Bleomycin therapy in advanced hodgkin's disease and epidermoid cancers.

Authors:  M B Mosher; R C DeConti; J R Bertino
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

5.  Treatment of advanced malignant lymphomas with bleomycin.

Authors:  R A Rudders
Journal:  Blood       Date:  1972-09       Impact factor: 22.113

6.  Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients.

Authors:  A Yagoda; B Mukherji; C Young; E Etcubanas; C Lamonte; J R Smith; C T Tan; I H Krakoff
Journal:  Ann Intern Med       Date:  1972-12       Impact factor: 25.391

7.  Cytotoxic-induced fulminant hyperpyrexia.

Authors:  D D Ma; J P Isbister
Journal:  Cancer       Date:  1980-05-01       Impact factor: 6.860

8.  Hyperpyrexia, allergic-type response and death occurring with low-dose bleomycin administration.

Authors:  R L Levy; S Chiarillo
Journal:  Oncology       Date:  1980       Impact factor: 2.935

9.  Bleomycin.

Authors:  J M Bennett; S D Reich
Journal:  Ann Intern Med       Date:  1979-06       Impact factor: 25.391

10.  Treatment of advanced lymphomas with bleomycin (NSC-125066).

Authors:  W J Durkin; R P Pugh; J Solomon; P Rosen; T F Pajak; J R Bateman
Journal:  Oncology       Date:  1976       Impact factor: 2.935

  10 in total
  2 in total

1.  Fulminant hyperpyrexia induced by bleomycin.

Authors:  W H Leung; J Y Lau; T K Chan; C R Kumana
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

2.  Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma.

Authors:  David A Bond; Emily Dotson; Farrukh T Awan; Robert A Baiocchi; Kristie A Blum; Kami Maddocks
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2018-11-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.